Medtainer, Inc. Completes Acquisition of Advanced Container Technologies

Lucida Medical (Cambridge University Spin-out) Joins GE Healthcare Edison™ Accelerator Programme

Lucida Medical was invited to join the Edison Accelerator programme for its pioneering work in helping identify prostate cancer and its exceptional development team led by Prof Evis Sala and Dr Antony Rix, both highly experienced in artificial intelligence, or AI, medical technology.

Boston Scientific Exercises Option to Acquire Farapulse, Inc.

FARAPULSE Pulsed Field Ablation (PFA) System is a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.  

Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System

Insulet will present new clinical outcomes data for preschool children with type 1 diabetes using the Omnipod 5 Automated Insulin Delivery System (Omnipod 5).

October 20, 2020

On October 9, 2020, Medtainer, Inc. consummated an exchange agreement with California-based Advanced Container Technologies, Inc. and its shareholders under which these shareholders exchanged their shares in ACT for 50,000,000 shares of Medtainer’s common stock. As a result, ACT has become the wholly-owned subsidiary of Medtainer.

In connection with this transaction, Medtainer, which is a Florida corporation, changed its name to Advanced Container Technologies, Inc., effective October 3, 2020, and its trading symbol to ACTX, effective 20 business days after October 9. On October 8, 2020, the outstanding shares of Medtainer’s common stock were reverse-split on the basis of one new share for every 59 shares outstanding. Medtainer now has 51,001,860 shares outstanding, which are held by 427 shareholders.

On August 6, 2020, ACT and GP Solutions, Inc. (“GP”), of Colton, California, entered into a Distributorship Agreement, under which ACT has the exclusive right to market, sell and distribute GP’s products in the United States and its territories. This agreement has an initial term that expires on December 31, 2025, and is renewable indefinitely as long as ACT meets prescribed sales targets. GP manufactures fully insulated, food-grade shipping containers that are specifically modified to provide an optimal controlled environment for growing a wide range of horticultural and agricultural products in all environments and climates. The containers can be used to grow large amounts products in a small volume and in a short period: for example, according to GP, 4,000 heads of romaine lettuce can be grown in a single container in less than 5 weeks.

Medtainer entered into the exchange agreement because its board of directors believed that the company needed to expand its product base and become profitable. Douglas P. Heldoorn, the chief executive officer of Medtainer and a member of its board of directors, stated: “Our sales have been relatively flat for the past several years and the Company has a history of losses. We are delighted to have acquired ACT and believe that it offers an opportunity to expand our products, enter into a new market and increase shareholder value.”

On October 9, Daniel Salinas, of Broken Arrow Oklahoma and Eric Horton, of San Diego California, were appointed to the board of directors, following the resignations of Russell Ward and Jeffory A. Carlson, and Mr. Carlson was appointed chief financial officer of Medtainer.



Trinity Health Names Mark LePage, M.D., as Senior Vice President of Medical Groups and Ambulatory Strategy

Prior to his time at IHA, LePage served as chief medical officer of Marshfield Clinic in Wisconsin

Jody Crane, MD Recognized by Modern Healthcare As One of the 50 Most Influential Clinical Executives

Dr. Crane’s work to streamline operations positioned and prepared TeamHealth and its clinicians to face the COVID-19 pandemic. Under Dr. Crane’s leadership, TeamHealth was able to maintain high levels of clinical quality throughout the rapidly changing COVID environment.

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

Subscribe to Medical Device News Magazine here.

Related Articles